Cargando…

Adherence to beta‐blockers and long‐term risk of heart failure and mortality after a myocardial infarction

AIMS: The aim of this study is to investigate the association between adherence to beta‐blocker treatment after a first acute myocardial infarction (AMI) and long‐term risk of heart failure (HF) and death. METHODS AND RESULTS: All patients admitted for a first AMI included in the nationwide Swedish...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desta, Liyew, Khedri, Masih, Jernberg, Tomas, Andell, Pontus, Mohammad, Moman Aladdin, Hofman‐Bang, Claes, Erlinge, David, Spaak, Jonas, Persson, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835575/ https://www.ncbi.nlm.nih.gov/pubmed/33259148 http://dx.doi.org/10.1002/ehf2.13079

Ejemplares similares

Angiotensin‐Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New‐Onset Atrial Fibrillation After Acute Myocardial Infarction
por: Batra, Gorav, et al.
Publicado: (2017)

Culprit vessel: impact on short-term and long-term prognosis in patients with ST-elevation myocardial infarction
por: Entezarjou, Artin, et al.
Publicado: (2018)

Higher risk of major adverse cardiac events after acute myocardial infarction in patients with schizophrenia
por: Attar, Rubina, et al.
Publicado: (2020)

β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational Study
por: Andell, Pontus, et al.
Publicado: (2015)

Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE‐SWEDEHEART Trial
por: Wester, Axel, et al.
Publicado: (2019)

Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
por: Andell, Pontus, et al.
Publicado: (2014)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

Delay From First Medical Contact to Primary PCI and All‐Cause Mortality: A Nationwide Study of Patients With ST‐Elevation Myocardial Infarction
por: Koul, Sasha, et al.
Publicado: (2014)

Intracoronary near-infrared spectroscopy and the risk of future cardiovascular events
por: Karlsson, Sofia, et al.
Publicado: (2019)

Circadian onset and prognosis of myocardial infarction with non-obstructive coronary arteries (MINOCA)
por: Nordenskjöld, Anna M., et al.
Publicado: (2019)

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)
por: Yndigegn, Troels, et al.
Publicado: (2022)

Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes
por: Ishak, Divan, et al.
Publicado: (2023)

Patient-oriented risk score for predicting death 1 year after myocardial infarction: the SweDen risk score
por: Rylance, Rebecca Tremain, et al.
Publicado: (2022)

Prevalence and prognostic impact of left ventricular systolic dysfunction or pulmonary congestion after acute myocardial infarction
por: Hamilton, Eleonora, et al.
Publicado: (2023)

Christmas, national holidays, sport events, and time factors as triggers of acute myocardial infarction: SWEDEHEART observational study 1998-2013
por: Mohammad, Moman A, et al.
Publicado: (2018)

Sex-differences in circulating biomarkers during acute myocardial infarction: An analysis from the SWEDEHEART registry
por: Eggers, Kai M., et al.
Publicado: (2021)

Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) – Study protocol from a randomized controlled trial
por: Sundh, Josefin, et al.
Publicado: (2020)

Reliability of estimating left ventricular ejection fraction in clinical routine: a validation study of the SWEDEHEART registry
por: Lenell, Joel, et al.
Publicado: (2022)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI
por: Koul, Sasha, et al.
Publicado: (2014)

On the Natural History of Coronary Artery Disease: A Longitudinal Nationwide Serial Angiography Study
por: Mohammad, Moman A., et al.
Publicado: (2022)

Peripheral artery disease and outcomes in patients with acute myocardial infarction
por: Attar, Rubina, et al.
Publicado: (2019)

Few with ST-segment elevation myocardial infarction are diagnosed within 10 minutes from first medical contact, and women have longer delay times than men
por: Muhrbeck, Josephine, et al.
Publicado: (2020)

Sex differences in potential triggers of myocardial infarction
por: Olsson, Anneli, et al.
Publicado: (2023)

Self‐Controlled Case‐Series Study to Verify the Effect of Adherence to Beta‐Blockers in Secondary Prevention of Myocardial Infarction
por: Di Bartolomeo, Stefano, et al.
Publicado: (2015)

Association of acute myocardial infarction with influenza: A nationwide observational study
por: Mohammad, Moman A., et al.
Publicado: (2020)

Clinical Outcomes of Calcium-Channel Blocker vs Beta-Blocker: From the Korean Acute Myocardial Infarction Registry
por: Kim, Moo Hyun, et al.
Publicado: (2023)

Adherence to Non-Selective Beta Blockers for Prevention of Variceal Bleeding in Cirrhotic Patients
por: An, Yang, et al.
Publicado: (2021)

Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction
por: Lindholm, Daniel, et al.
Publicado: (2019)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?
por: Giannakopoulos, Georgios, et al.
Publicado: (2021)

Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it
por: Joo, Seung-Jae
Publicado: (2023)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
por: Carubelli, Valentina, et al.
Publicado: (2021)

β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction
por: Dondo, Tatendashe B., et al.
Publicado: (2017)

Beta-Blockers for the Secondary Prevention of Myocardial Infarction in People with Dementia: A Systematic Review
por: Lanham, David, et al.
Publicado: (2019)

Usefulness of universal beta-blocker therapy in patients after ST-elevation myocardial infarction
por: Ferreira, João André, et al.
Publicado: (2021)

Should beta‐blockers be continued as a treatment for myocardial infarction in the case of Kounis syndrome?
por: Amino, Mari, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vfdlkae8mp1hidftgcncgig51i